Irell Wins M&A Advisor Award for Representing Creditors Committee in Sale of Orexigen Therapeutics

Irell & Manella LLP’s representation of the official unsecured creditors’ committee in the 2018 sale of Orexigen Therapeutics, Inc. earned the firm the “Healthcare/Life Sciences Deal of the Year” award for deals under $500 million at The M&A Advisor’s Turnaround Awards. The honors are given annually to the leading transactions, firms and individuals in the distressed investing and reorganization industry.